Correlation Between Neximmune and Keros Therapeutics

Can any of the company-specific risk be diversified away by investing in both Neximmune and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neximmune and Keros Therapeutics, you can compare the effects of market volatilities on Neximmune and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Keros Therapeutics.

Diversification Opportunities for Neximmune and Keros Therapeutics

0.0

Correlation Coefficient

Neximmune  Keros Therapeutics

Pay attention - limited upside

The 3 months correlation between Neximmune and Keros is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Neximmune i.e., Neximmune and Keros Therapeutics go up and down completely randomly.

Pair Corralation between Neximmune and Keros Therapeutics

If you would invest (100.00) in Neximmune on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Neximmune or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Neximmune  vs.  Keros Therapeutics

Neximmune

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Keros Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Keros Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Neximmune and Keros Therapeutics

The main advantage of trading using opposite Neximmune and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.

The idea behind Neximmune and Keros Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.